title: [Importance of Post-Marketing Studies in Gathering of Clinical Evidences for Proper Usage of Anti-Cancer Drugs, and the StudyRequirements for Their Credibility].
abstract: Pharmaceutical companies recognize the importance of post-marketing studies because they are crucial in the generation of clinical evidences for the usage of new medicines. To generate clinical evidences, quality of post-marketing studies should be well controlled from view point of "ethical conduction" and "reliability of results". In addition, control of conflict of interest (COI) between researchers and industries is also indispensable and is requested for the transparency of the studies. Japan Pharmaceutical Manufacturers Association(JPMA)stresses its commitment to the progressof transparency in post-marketing studies.
authors.affiliation: Chairperson, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association.
authors.forename: Osamu
authors.initials: O
authors.lastname: Inagaki
mesh_terms: D000970:Antineoplastic Agents / Q000592:standards / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D008389:Marketing of Health Services
chemical_list: D000970:Antineoplastic Agents